Constantin Dreher

University Medical Centre Mannheim, Heidelberg University

Papers

2

Total Citations

24

H-Index

2

About

Constantin Dreher is a leading researcher in radiation oncology, specializing in stereotactic body radiotherapy (SBRT) for liver malignancies. His primary research focuses on active motion-compensation techniques to precisely target liver tumors while minimizing damage to healthy tissue. Dreher’s most impactful work, a 2021 pooled multi-platform cohort study with 21 citations, demonstrated that liver SBRT with active motion-compensation achieves excellent local control for oligometastases, establishing a new standard for treating liver tumors that move with respiration. In a subsequent 2023 pooled analysis, he provided the first long-term characterization of MRI-morphologic alterations in normal liver tissue after motion-compensated SBRT, offering critical insights for multimodal treatment planning. This work helps clinicians anticipate and manage radiation-induced changes in the liver over time. Dreher’s contributions are particularly valuable for patients with limited metastatic disease, where precise, high-dose radiation can be curative. By integrating advanced imaging with motion management, he has advanced the safety and efficacy of liver SBRT, making him a key figure in modern radiation oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
24
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases: An outcome analysis of a pooled multi-platform patient cohort
21 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: University Medical Centre Mannheim, Heidelberg University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago